Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Cecilia Pirovano is a leading gynecologic oncologist whose research focuses on advancing minimally invasive surgical techniques for cervical cancer treatment. Her major contributions center on comparing robotic and laparoscopic radical hysterectomy outcomes, demonstrating that robotic approaches offer comparable long-term oncologic safety to traditional laparoscopy while potentially improving surgical precision. Her landmark 2017 study (26 citations) provided crucial long-term follow-up data on robotic versus laparoscopic radical hysterectomy for cervical cancer, establishing evidence that robotic surgery does not compromise survival outcomes. Dr. Pirovano has also pioneered research on robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer (24 citations), showing that robotic surgery remains safe and effective even in complex, pre-treated cases. Her health economics research (17 and 7 citations) has been instrumental in demonstrating that minimally invasive approaches, particularly robotic surgery, can be cost-effective when performed by experienced surgeons in specialized centers. Through her single-surgeon series from an Italian oncological referral center, Dr. Pirovano has provided valuable real-world evidence supporting the adoption of robotic techniques in gynecologic oncology, helping to shape surgical standards for cervical cancer management worldwide.